Perspective
Featured Topics
Lead story
Other featured articles
-
Comments on Enhancing Coverage of Preventive Services Under the Affordable Care Act
Removing prescribing requirements and cost barriers could significantly improve access to contraception. However, successful implementation will require careful consideration of operational processes.
Posted in -
Government Needs to Do More to Ensure Obesity Drug Safety
Expanding coverage for anti-obesity medications without reforming compounding regulation will exacerbate problems with counterfeit drugs. The incoming administration should modernize manufacturing techniques, shore up the supply chain and ban compounding of new obesity medications.
Posted in -
Comments to CMS on Proposed $2 Drug List Model
Transparent, simple plan benefits like the proposed model, as well as transparent cost structures throughout the system, have valuable impacts for the beneficiary and the potential to help align incentives throughout the distribution system.
Posted in -
Medicare Advantage Costs Taxpayers 22% More Per Enrollee. Here’s How Payment Reform Could Help Close the Gap.
The Medicare Advantage payment system needs a broad reform that aligns insurers’ incentives with the needs of beneficiaries and taxpayers.
Posted in
ADDITIONAL Perspectives
-
Podcast: Schaeffer Scholar Discusses the Side Effects of Legal Cannabis
Rosalie Liccardo Pacula, a leading expert on cannabis policy, discusses the public health and social equity impacts of rapidly changing marijuana laws on the PricePod.
Categorized in -
Opinion: I’m a Doctor in East L.A. and Beverly Hills. I Want to Treat Obesity the Same Way in Both Places
Use of newer anti-obesity medications in any part of town can provide true benefit even if lifestyle changes are harder to implement.
Categorized in -
Medicare vs. Medicare Advantage: The Choices Can Be OverwhelmingÂ
Nearly 70 million Medicare-eligible Americans have complicated coverage decisions during open enrollment, and they often face biased sales pitches or may lack access to impartial help.
Categorized in -
The CBO Report on Medicare and Anti-Obesity Medications Should Not Be the Final Word
The highly anticipated report contains clues on how Congress may come to a different view on medications like Wegovy and Zepbound.
Categorized in -
Lessons From the Change Healthcare Ransomware Attack
The harrowing cyberattack on Change Healthcare provides an opportunity for the public and private sector to clarify cybersecurity priorities and focus on vital measures to secure the health care system.
Categorized in -
How the Next President Should Reform Medicare
If left alone, Medicare Advantage will increasingly push overall costs in Medicare into unsustainable territory. Needed reforms can be phased in over a period of years.
Categorized in